Genomatica, a San Diego-based developer of sustainable chemicals, has filed with the SEC for an initial public offering (IPO) of up to $100 million. The number of shares offered and the price range of the offering have not been determined. Founded in 2000, the company has built momentum behind its 1,4-butanediol (BDO) production technology, signing joint venture deals with Mitsubishi Chemical and Novamont. Earlier this week the company announced its second commercial target will be biobased butadiene. Genomatica has intellectual property covering the production...
Already an IHS Chemical Week member? Login here
Forgot your user ID or password? Click here to have it sent to you.
Click here for 6 months access to the lates news, data and statistics on sustainability. PLUS all the news and analysis from the Chemical Week editorial team updated everyday on IHS Chemical Week